Scientific Program

 

7:55 – 8:00 a.m.
WELCOME AND OVERVIEW

Academy Chairs
 

8:00 – 9:00 a.m.
SESSION 1 – HEART FAILURE: OVERVIEW AND EVALUATION

Chair: Anique Ducharme, MD, MSC, Montréal Heart Institute, Montréal, Canada
 
8:00 a.m. – Case Presentation (3 minutes)
Jacinthe Boulet, MD CM, FRCPC, Harvard Medical School, Boston, MA, USA

8:03 a.m. – Heart Failure: General Overview and Concepts (12 minutes)
Sonia Mirabet Perez, MD, Hospital Sant Pau, Barcelona, Spain

Teaching/Discussion Points
  1. Scope of the problem
  2. Pathophysiology
  3. Causes of heart failure
  4. Multidisciplinary Team Approach, Patient partnership
     
8:15 a.m. – Evaluation of Patients with Heart Failure (15 minutes)
Michelle Kittleson, MD, PhD, Cedars Sinai Heart Institute, Los Angeles, CA, USA

Teaching/Discussion Points
  1. Signs and symptoms
  2. Biomarkers
  3. Screening guidelines
  4. Risk stratification
  5. Indicators for advance therapy referral
     
8:30 a.m. – Heart Failure Tests (15 minutes)
Marco Masetti, MD, PhD, University of Bologna, Bologna, Italy

Teaching/Discussion Points
  1. Role of right heart catherization and hemodynamic monitoring
  2. Cardiopulmonary exercise testing interpretation
  3. When to perform endomyocardial biopsy
  4. Ischemia evaluation
  5. Added benefits of MRI
  6. Genetics?
     
8:45 a.m. – Q&A with Panel (15 minutes)
 

9:00 – 10:15 a.m.
SESSION 2 – MANAGEMENT OF PATIENTS WITH ADVANCED HEART FAILURE and SHOCK

Chair: Alejandro M. Bertolotti, MD, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina
 
9:00 a.m. – Case Presentation (3 minutes)
Jacinthe Boulet, MD CM, FRCPC, Harvard Medical School, Boston, MA, USA

9:03 a.m. – Non-Pharmacologic and Pharmacologic Management (15 minutes)
Michelle Kittleson, MD, PhD, Cedars Sinai Heart Institute, Los Angeles, CA, USA

Teaching/Discussion Points
  1. Sodium and fluid management
  2. Risk factor modification (obesity, inactivity, sleep apnea, HTN, DM, smoking)
  3. Guideline recommendations
  4. Update on novel therapeutic approaches
  5. Palliative care Home inotropes
     
9:18 a.m. – Principles for Arrhythmia Management and Electrical Devices (12 minutes)
Eileen Hsich, MD, Cleveland Clinic, Cleveland, OH, USA

Teaching/Discussion Points
  1. Atrial fibrillation management
  2. Ventricular arrhythmias
  3. Implantable cardioverter-defibrillator
  4. Cardiac resynchronization therapy
     
9:30 a.m. – Surgical/interventional Management of Heart Failure (15 minutes)
Ivan Knezevic, MD, PhD, University Medical Centre Ljubljana, Ljubljana, Slovenia

Teaching/Discussion Points
  1. The concept of Heart Team
  2. Coronary Disease: High risk PCI vs. surgical revascularization
  3. Valve Disease: Surgical options
  4. Transcatheter Edge to Edge Repair and other percutaneous devices for Valves Disease Management
     
9:45 a.m. Cardiogenic Shock (15 minutes)
Jerry Estep, MD, Cleveland Clinic, Cleveland, OH, USA

Teaching/Discussion Points
  1. Recognition of shock
  2. SCAI classification and outcomes
  3. Short term options for mechanical circulatory support (algorithm: intra-aortic balloon pump, ECMO, percutaneous mechanical circulatory support)
     
10:00 a.m. – Q&A with Panel (15 minutes)
 

10:15 – 10:45 a.m.
COFFEE BREAK

 

10:45 a.m. – 12:00 p.m.
SESSION 3 – CARDIAC TRANSPLANTATION AND ALTERNATIVES

Chair: Yael Peled, MD, Sheba Medical Center, Tel Aviv, Israel
 
10:45 a.m – Case Presentation (3 minutes)
Eyal Nachum, MD. Sheba Medical Center, Tel Aviv, Israel

10:48 a.m. – Consideration for Advanced Heart Failure Therapies (17 minutes)
Marco Masetti, MD, PhD, University of Bologna, Bologna, Italy

Teaching/Discussion Points
  1. Timing of referral
  2. Special considerations (including Group O, large body habitus)
  3. Volume and center’s experience
     
11:05 a.m. – Pulmonary Hypertension: Pulmonary Arterial Hypertension in Heart Failure (15 minutes)
Maxime Tremblay-Gravel, MD, MSc, Montréal Heart Institute, Montréal, Canada

Teaching/Discussion Points
  1. Definition
  2. WHO classification
  3. Etiologies
  4. Medical therapies
  5. Procedures and Monitoring
     
11:20 a.m. – Evaluation of the Transplant Candidate (25 minutes)
Anique Ducharme, MD, MSC, Montréal Heart Institute, Montréal, Canada

Teaching/Discussion Points
  1. Multidisciplinary approach of heart transplant candidates
  2. Indications for transplant
  3. Contraindications for transplant
  4. Evaluation process (Guidance for screening grids and serial pre-transplant evaluation)
  5. RHC interpretation
  6. Substance abuse, tobacco use, and cannabis
     
11:45 a.m. – Q&A with Panel (15 minutes)
 

12:00 – 1:00 p.m.
LUNCH BREAK

 

1:00 – 1:45 p.m.
SESSION 4 – CARDIAC TRANSPLANTATION – SPECIAL CONSIDERATIONS

Chair: Anique Ducharme, MD, MSC, Montréal Heart Institute, Montréal, Canada
 
1:00 p.m. – Difficult Decision Making (15 minutes)
Anique Ducharme, MD, MSC, Montréal Heart Institute, Montréal, Canada

Teaching/Discussion Points
  1. Restrictive and infiltrative cardiomyopathies
  2. Chagas Disease
  3. Retransplantation
  4. Considerations for multi organ transplant
     
1:15 p.m – The Nightmare of Pediatric and Adult Congenital Disease (15 minutes)
Lori West, MD, DPhil, Alberta Transplant Institute, Edmonton, AB, Canada

Teaching/Discussion Points
  1. Pediatric transplantation
  2. Adult congenital patient
     
1:30 p.m. – Q&A with Panel (15 minutes)
 

1:45 – 3:45 p.m.
SESSION 5 – GUIDING PRINCIPLES: DONOR RECIPIENT MATCH and IMMUNOLOGY 101

Chair: Yael Peled, MD, Sheba Medical Center, Tel Aviv, Israel
 
1:45 p.m. – Case Presentation (3 minutes)
Mónica Gilbert, MD, Clinica Guayaquil, Guayas, Ecuador

1:48 p.m. – Balancing the Risk (20 minutes)
Yael Peled, MD, Sheba Medical Center, Tel Aviv, Israel

Teaching/Discussion Points
  1. Donor risk factors
  2. Recipient risk factors in the context of donor heart selection
  3. Balancing donor and recipient risk in donor selection (Ischemic Time & Risks score)
  4. Extended criteria donor hearts (including DCD donor and Ex-Vivo Perfusion)
     
2:08 p.m. – Heart Transplant Procedure: Pre, Intra and Postoperative Aspects of Care (17 minutes)
Alejandro M. Bertolotti, MD, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina

Teaching/Discussion Points
  1. Patient prioritization and risk stratification
  2. Technical aspects of heart transplant procedure
  3. Postoperative care: common scenarios
  4. Primary Graft Dysfunction: diagnosis and management
     
2:25 p.m. – Overview of Transplantation Immunobiology (20 minutes)
Jon Kobashigawa, MD, Cedars Sinai Heart Institute, Los Angeles, CA, USA

Teaching/Discussion Points
  1. Immunology 101
  2. Immunosuppression strategies
  3. Sensitized patient
     
2:45 p.m. – Disease Management Strategies (Rejection, Immunosuppression, Infections and Complications) (15 minutes)
Eileen Hsich, MD, Cleveland Clinic, Cleveland, OH, USA

Teaching/Discussion Points
  1. Rejection surveillance and treatment
  2. Common infectious considerations
  3. Common medical complications (bone disease, etc.)
     
3:00 p.m. – Special Consideration of Immunosuppression (20 minutes)
Jon Kobashigawa, MD, Cedars Sinai Heart Institute, Los Angeles, CA, USA

Teaching/Discussion Points
  1. Pros and Cons of Induction therapy
  2. Minimizing Immunosuppression, including steroid withdrawal/avoidance
     
3:20 p.m. – Q&A with Panel (15 minutes)
 

3:35 – 4:05 p.m.
COFFEE BREAK

 

4:05 – 5:10 p.m.
SESSION 6 – MECHANICAL CIRCULATORY SUPPORT

Chair: Alejandro M. Bertolotti, MD, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina
 
4:05 p.m. – Case Presentation (3 minutes)
Eyal Nachum, MD, Sheba Medical Center, Tel Aviv, Israel

4:08 p.m. – Current Devices and Outcomes (22 minutes)
Alejandro M. Bertolotti, MD, Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina

Teaching/Discussion Points
  1. History of device development (very brief)
    1. Continuous vs Pulsatile devices
    2. Axial vs Centrifugal flow
    3. TAH versus BiVAD
  2. Scoring systems (RV and bleeding)
  3. Candidate selection
     
4:30 pm. – Chronic Complications in Mechanical Circulatory Support (20 minutes)
Diyar Saeed, MD, PhD, Leipzig Heart Center, Leipzig, Germany

Teaching/Discussion Points
  1. GI bleeding
  2. CVA
  3. Driveline infections
  4. Aortic insufficiency
  5. Pump thrombosis
  6. Late RV failure
     
4:50 p.m. – Q&A with Panel (20 minutes)
 

5:10 – 5:15 p.m.
COURSE SUMMARY AND EVALUATION

Anique Ducharme, MD, MSC, Montréal Heart Institute, Montréal, Canada
 

5:15 p.m.
ADJOURN

Back to 2022 Academies

Related Items